| Collection |
D4 : TTD |
| Chemical Name |
Dermolastin ( From PubChem : N B - 5 9 8 ) |
| FDA |
NPC |
WHO |
Indian |
Australia |
China |
Traditional
Herbal |
Clinical
Trail |
| Not | Not | Not | Not | Not | Not | Not | Not |
|
Molecular
Weight |
Hydrogen Bond
Donor Count |
Hydrogen Bond
Acceptor Count |
cLogP |
Lipinski Rule |
| 449.671 g/mol |
0 |
4 |
7.4832 |
False(3/4) |
|
| Structure |
|
| InChI |
I n C h I = 1 S / C 2 7 H 3 1 N O S 2 / c 1 - 5 - 2 8 ( 1 4 - 8 - 6 - 7 - 1 3 - 2 7 ( 2 , 3 ) 4 ) 1 8 - 2 2 - 1 0 - 9 - 1 1 - 2 5 ( 1 6 - 2 2 ) 2 9 - 1 9 - 2 6 - 1 7 - 2 4 ( 2 1 - 3 1 - 2 6 ) 2 3 - 1 2 - 1 5 - 3 0 - 2 0 - 2 3 / h 6 , 8 - 1 2 , 1 5 - 1 7 , 2 0 - 2 1 H , 5 , 1 4 , 1 8 - 1 9 H 2 , 1 - 4 H 3 / b 8 - 6 + |
| InChIKey |
K I R G L C X N E V I C O G - S O F G Y W H Q S A - N
|
| Links |
|
Gene
(5 /
13)
⊖ Less
|
| Source | Type | Unit | Value | Gene | PMID | Assay | Other | | TTD | Multitarget | CTSG | | | Clinical trial target | | TTD | Inhibitor | CTSG | | | Clinical trial target | | TTD | Drug(s) | CTSG | | | Clinical trial target | | TTD | Multitarget | ELANE | | | Successful target | | TTD | Inhibitor | ELANE | | | Successful target | | TTD | Drug(s) | ELANE | | | Successful target | | TTD | Multitarget | F2 | | | Successful target | | TTD | Inhibitor | F2 | | | Successful target | | TTD | Drug(s) | F2 | | | Successful target | | TTD | Multitarget | KLK2 | | | Clinical trial target | | TTD | Inhibitor | KLK2 | | | Clinical trial target | | TTD | Drug(s) | KLK2 | | | Clinical trial target | | TTD | Inhibitor | SQLE | | | Successful target |
|
| Download gene sets |
gmt, text, Detailed text
|
